T0	Participants 101 124	advanced breast cancer.
T1	Participants 180 203	advanced breast cancer.
T2	Participants 473 562	Patients with newly diagnosed metastatic breast cancer or locally recurrent breast cancer
T3	Participants 739 784	The P600 (47 patients) and P900 (45 patients)